IN2014KN01374A - - Google Patents
Info
- Publication number
- IN2014KN01374A IN2014KN01374A IN1374KON2014A IN2014KN01374A IN 2014KN01374 A IN2014KN01374 A IN 2014KN01374A IN 1374KON2014 A IN1374KON2014 A IN 1374KON2014A IN 2014KN01374 A IN2014KN01374 A IN 2014KN01374A
- Authority
- IN
- India
- Prior art keywords
- resistance
- cells
- identification
- generation
- cell cultures
- Prior art date
Links
- 108010039491 Ricin Proteins 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 210000003783 haploid cell Anatomy 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000032537 response to toxin Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/02—Drug screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11191408.1A EP2599859A1 (en) | 2011-11-30 | 2011-11-30 | Haploid cells |
| US201161565626P | 2011-12-01 | 2011-12-01 | |
| PCT/EP2012/074112 WO2013079670A1 (en) | 2011-11-30 | 2012-11-30 | Haploid cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014KN01374A true IN2014KN01374A (enExample) | 2015-10-16 |
Family
ID=45218335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1374KON2014 IN2014KN01374A (enExample) | 2011-11-30 | 2012-11-30 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20140342369A1 (enExample) |
| EP (2) | EP2599859A1 (enExample) |
| JP (1) | JP2015500637A (enExample) |
| KR (1) | KR20140101390A (enExample) |
| CN (1) | CN104024404A (enExample) |
| AU (1) | AU2012343826A1 (enExample) |
| CA (1) | CA2856810A1 (enExample) |
| IL (1) | IL232879A0 (enExample) |
| IN (1) | IN2014KN01374A (enExample) |
| SG (1) | SG11201402350QA (enExample) |
| WO (1) | WO2013079670A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9957479B2 (en) | 2011-03-02 | 2018-05-01 | Anton Wutz | Mammalian haploid embryonic stem cells |
| WO2015152146A1 (ja) * | 2014-03-31 | 2015-10-08 | 国立大学法人東京医科歯科大学 | １倍体胚性幹細胞の培養方法 |
| CA2993476A1 (en) * | 2015-07-29 | 2017-02-02 | New York Stem Cell Foundation, Inc. | Haploid human embryonic stem cell lines and somatic cell lines and methods of making the same |
| WO2017221225A1 (en) * | 2016-06-19 | 2017-12-28 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Screening for chemotherapy resistance in human haploid cells |
| JP7026304B2 (ja) | 2016-07-29 | 2022-02-28 | マックス－プランク－ゲゼルシャフト ツア フェルデルンク デア ヴィッセンシャフテン エー．ファウ． | 部位特異的ｄｎａ開裂及び修復による標的化原位置タンパク質多様化 |
| EP3388530A1 (en) | 2017-04-13 | 2018-10-17 | IMBA-Institut für Molekulare Biotechnologie GmbH | Nucleic acid modification and identification method |
| ES3043187T3 (en) | 2017-04-13 | 2025-11-25 | Imba Inst Molekulare Biotech | Nucleic acid modification and identification method |
| CN108998410B (zh) * | 2017-06-07 | 2020-11-06 | 中国科学院动物研究所 | 蛋白激酶抑制剂在抑制单倍体细胞二倍化中的用途 |
| CN107217042B (zh) * | 2017-07-31 | 2020-03-06 | 江苏东抗生物医药科技有限公司 | 一种生产无岩藻糖基化蛋白的基因工程细胞系及其建立方法 |
| US10626319B1 (en) | 2019-05-17 | 2020-04-21 | King Fahd University Of Petroleum And Minerals | Methods of inhibiting corrosion with a pyrazine corrosion inhibitor |
| EP4183873A4 (en) * | 2020-07-17 | 2024-04-24 | Tohoku University | Trophoblast stem cell-like cells capable of differentiating into placenta-constituting cells, and method for producing same |
| CN118389411A (zh) * | 2024-06-21 | 2024-07-26 | 中国科学院昆明动物研究所 | 一种小鼠双单倍体胚胎干细胞分离建系的方法 |
| CN118370275B (zh) * | 2024-06-21 | 2024-09-06 | 中国科学院昆明动物研究所 | 一种产生母源性半克隆小鼠的方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5945577A (en) | 1997-01-10 | 1999-08-31 | University Of Massachusetts As Represented By Its Amherst Campus | Cloning using donor nuclei from proliferating somatic cells |
| EP1092768A1 (en) | 1999-10-16 | 2001-04-18 | ARTEMIS Pharmaceuticals GmbH | Conditional gene trapping construct for the disruption of genes |
| CN100497598C (zh) | 1999-10-28 | 2009-06-10 | 马萨诸塞大学 | 多能细胞和细胞系的单雌生殖或单雄生殖产生,及其产生分化细胞和组织的用途 |
| AU1581001A (en) | 1999-11-02 | 2001-05-14 | University Of Massachusetts | Use of haploid genomes for genetic diagnosis, modification and multiplication |
| US7074611B2 (en) | 2001-04-27 | 2006-07-11 | Gie-Cerbn, Centre Europeen De Recherche En Biologie Et En Medecine (Gie) | Method for the stable inversion of DNA sequence by site-specific recombination and DNA vectors and transgenic cells thereof |
| AU2003297700A1 (en) | 2002-12-09 | 2004-06-30 | Boehringer Ingelheim Pharmaceuticals, Inc. | METHODS FOR MODULATING IKKAlpha ACTIVITY |
| HUE028026T2 (en) | 2002-12-16 | 2016-11-28 | Technion Res & Dev Foundation | Breeding system free of native cells, free of foreign matter for human embryonic stem cells |
| EP1662005A1 (en) | 2004-11-26 | 2006-05-31 | FrankGen Biotechnologie AG | Enhancer-containing gene trap vectors for random and targeted gene trapping |
| DK1815001T3 (da) | 2004-11-26 | 2011-05-16 | Helmholtz Zentrum Muenchen | Genfældekassetter til tilfældig og målrettet konditioneret geninaktivering |
| US20100069251A1 (en) | 2006-09-15 | 2010-03-18 | Children's Medical Center Corporation | Methods for producing embryonic stem cells from parthenogenetic embryos |
| CN104651299B (zh) * | 2007-04-06 | 2022-07-26 | 国际干细胞公司 | 源于人单性生殖胚泡的患者特异性干细胞系 |
| US9957479B2 (en) * | 2011-03-02 | 2018-05-01 | Anton Wutz | Mammalian haploid embryonic stem cells |
-
2011
- 2011-11-30 EP EP11191408.1A patent/EP2599859A1/en not_active Withdrawn
-
2012
- 2012-11-30 CA CA2856810A patent/CA2856810A1/en not_active Abandoned
- 2012-11-30 EP EP12791811.8A patent/EP2785832A1/en not_active Withdrawn
- 2012-11-30 AU AU2012343826A patent/AU2012343826A1/en not_active Abandoned
- 2012-11-30 JP JP2014543917A patent/JP2015500637A/ja active Pending
- 2012-11-30 SG SG11201402350QA patent/SG11201402350QA/en unknown
- 2012-11-30 CN CN201280065785.XA patent/CN104024404A/zh active Pending
- 2012-11-30 US US14/361,655 patent/US20140342369A1/en not_active Abandoned
- 2012-11-30 WO PCT/EP2012/074112 patent/WO2013079670A1/en not_active Ceased
- 2012-11-30 KR KR1020147017705A patent/KR20140101390A/ko not_active Withdrawn
- 2012-11-30 IN IN1374KON2014 patent/IN2014KN01374A/en unknown
-
2014
- 2014-05-29 IL IL232879A patent/IL232879A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2785832A1 (en) | 2014-10-08 |
| IL232879A0 (en) | 2014-07-31 |
| US20140342369A1 (en) | 2014-11-20 |
| AU2012343826A1 (en) | 2014-06-12 |
| KR20140101390A (ko) | 2014-08-19 |
| CA2856810A1 (en) | 2013-06-06 |
| SG11201402350QA (en) | 2014-06-27 |
| CN104024404A (zh) | 2014-09-03 |
| WO2013079670A1 (en) | 2013-06-06 |
| JP2015500637A (ja) | 2015-01-08 |
| EP2599859A1 (en) | 2013-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014KN01374A (enExample) | ||
| MY183741A (en) | Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair | |
| NZ627373A (en) | Genes involved in noscapine production | |
| MX2014012994A (es) | Direccion transmitida por nucleasa con vectores de direccion grandes. | |
| EA024121B9 (ru) | Композиции эндорибонуклеаз и способы их использования | |
| ZA201606933B (en) | Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair | |
| MX421064B (es) | Composiciones de nanoparticulas lipidicas y metodos para administracion de arnm | |
| SG10201809901SA (en) | Generating Pluripotent Cells De Novo | |
| NZ628549A (en) | Novel class of glyphosate resistance genes | |
| NZ811395A (en) | Mutated protoporphyrinogen ix oxidase (ppx) genes | |
| IN2014DN10996A (enExample) | ||
| MX2014000301A (es) | Métodos para mejorar el rendimiento y la tolerancia al estrés es una planta. | |
| PH12015500213A1 (en) | Production of fmdv-resistant livestock by allele substitution | |
| PH12013501409A1 (en) | Nucleic acid molecules that confer resistance to coleopteran pests | |
| WO2013188638A3 (en) | Endoribonucleases and methods of use thereof | |
| MX2020010524A (es) | Composiciones y metodos para inhibir la expresion del gen de alfa-1 antitripsina. | |
| IN2014MN01569A (enExample) | ||
| EP3042180A4 (en) | Cell culturing and tracking with oled arrays | |
| IN2015KN00073A (enExample) | ||
| WO2012169969A8 (en) | Genetic manipulation and expression systems for pucciniomycotina and ustilaginomycotina subphyla | |
| MX368901B (es) | Interferencia de la represion del factor de transcripcion hd-zip de expresion genica para la produccion de plantas con rasgos mejorados. | |
| MY171760A (en) | Microorganisms and methods for the production of caprolactone | |
| MX2010002304A (es) | Metodos para incorporar multiples genes en una planta de cultivo. | |
| IN2012DN01604A (enExample) | ||
| MY191390A (en) | Methods and compositions for increasing efficiency of increased efficiency of targeted gene modification using oligonucleotide-mediated gene repair |